Fluorine in PDB 6ncj: Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors

Protein crystallography data

The structure of Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors, PDB code: 6ncj was solved by R.T.Nolte, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 31.57 / 2.00
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 72.290, 72.290, 64.790, 90.00, 90.00, 120.00
R / Rfree (%) 19.4 / 24

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors (pdb code 6ncj). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors, PDB code: 6ncj:

Fluorine binding site 1 out of 1 in 6ncj

Go back to Fluorine Binding Sites List in 6ncj
Fluorine binding site 1 out of 1 in the Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure of Hiv-1 Integrase with Potent 5,6,7,8-Tetrahydro-1,6- Naphthyridine Derivatives Allosteric Site Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F305

b:23.9
occ:1.00
F12 A:KJJ305 0.0 23.9 1.0
C5 A:KJJ305 1.3 25.8 1.0
C4 A:KJJ305 2.3 25.2 1.0
C6 A:KJJ305 2.4 25.0 1.0
O11 A:KJJ305 2.7 24.5 1.0
CB A:ALA129 3.1 16.2 1.0
CA A:ALA129 3.3 16.1 1.0
N A:ALA129 3.3 18.1 1.0
CD1 A:LEU102 3.3 14.6 0.4
O A:THR125 3.5 20.8 1.0
C3 A:KJJ305 3.6 25.4 1.0
C7 A:KJJ305 3.7 25.4 1.0
CG A:LEU102 3.7 15.5 0.4
CB A:ALA98 3.8 16.4 1.0
C A:ALA128 4.1 21.2 1.0
CD2 A:LEU102 4.1 19.1 0.4
C10 A:KJJ305 4.2 23.5 1.0
C2 A:KJJ305 4.2 25.7 1.0
C25 A:KJJ305 4.2 20.6 1.0
O A:ALA98 4.2 16.7 1.0
C A:ALA98 4.4 18.1 1.0
CB A:ALA128 4.4 18.5 1.0
CA A:ALA98 4.5 16.2 1.0
C A:THR125 4.6 23.4 1.0
O A:ALA128 4.6 20.4 1.0
CD2 A:LEU102 4.6 18.9 0.6
C A:ALA129 4.8 17.4 1.0
C13 A:KJJ305 4.8 26.4 1.0
CA A:ALA128 4.8 18.5 1.0
C8 A:KJJ305 4.9 24.8 1.0
CB A:LEU102 5.0 14.2 0.6

Reference:

K.M.Peese, C.W.Allard, T.Connolly, B.L.Johnson, C.Li, M.Patel, M.E.Sorensen, M.A.Walker, N.A.Meanwell, B.Mcauliffe, B.Minassian, M.Krystal, D.D.Parker, H.A.Lewis, K.Kish, P.Zhang, R.T.Nolte, J.Simmermacher, S.Jenkins, C.Cianci, B.N.Naidu. 5,6,7,8-Tetrahydro-1,6-Naphthyridine Derivatives As Potent Hiv-1-Integrase-Allosteric-Site Inhibitors. J. Med. Chem. V. 62 1348 2019.
ISSN: ISSN 1520-4804
PubMed: 30609350
DOI: 10.1021/ACS.JMEDCHEM.8B01473
Page generated: Sun Dec 13 12:59:35 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy